🇺🇸 FDA
Patent

US 7094424

Cationic lipid compositions targeting angiogenic endothelial cells

granted A61KA61K47/54A61K47/543

Quick answer

US patent 7094424 (Cationic lipid compositions targeting angiogenic endothelial cells) held by The Regents of the University of California expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/54, A61K47/543, A61K49/0032, A61K49/0041